Skip to main content
Premium Trial:

Request an Annual Quote

ForteBio, Martin Wells, Chris Brannen, Jason Attanucci, Peter Kraus

Premium

New Products

ForteBio announced this week the introduction of its first product — the Octet System for label-free, real-time detection and analysis of molecular interactions.

The Octet System is based on a proprietary technique called BioLayer Interferometry. It incorporates a sensitive optical detector and a series of application-specific biosensor consumables. According to ForteBio, the biosensors provide a way to make critical measurements even in crude samples, at early stages in antibody development.

 

Movers & Shakers

Nonlinear Dynamics has appointed Martin Wells as international sales manager, Chris Brannen as Western regional sales manager, and Jason Attanucci as Eastern regional sales manager of the company's US subsidiary, Nonlinear USA Inc. Nonlinear has also named Peter Kraus as a field applications scientist.

Wells joins Nonlinear from Helena BioSciences, where he worked for 13 years in a variety of senior sales and marketing positions. Brannen joins Nonlinear after three years with Bio-Rad Laboratories, where he served as sales account manager. Attanucci was previously national sales manager for ChemImage, an imaging technology firm. Kraus joins the company from postdoctoral research positions with both Yale University and Duke University Medical Center after obtaining a PhD in biomedical sciences from the University of Connecticut in 2001.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.